A comparison of uric acid levels in black African vs Caucasian women from South Africa: The powirs study

Ethnicity and Disease

Volumn 17, Issue 4, 2007, Pages 676-681

  Palmer, I M ^a   Schutte, A E ^a   Huisman, H W ^a   Van Rooyen, J M ^a   Schutte, R ^a   Malan, L ^a   Malan, N T ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

African; Cardiovascular function; Caucasian; Metabolic syndrome; Uric acid

Indexed keywords

URIC ACID;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; METABOLIC SYNDROME X; NEGRO; RISK FACTOR; STATISTICAL SIGNIFICANCE; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; DIET SURVEYS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; METABOLIC SYNDROME X; OBESITY; SOUTH AFRICA; URIC ACID;

EID: 36348936857     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Seedat YK. Hypertension in Black South Africans. J Hum Hypertens. 1999;13(11): 96-103.
2. Van Rooyen JM, Kruger HS, Huisman HW, Wissing MP, Margetts BM, Venter CS. An epidemiological study of hypertension and its determinants in a population in transition: the THUSA study. J Hum Hypertens. 2000; 14(12):779-787.
3. Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation. 2005;112(23):3562-3568.
4. Vorster HH, Venter CS, Wissing MP, Margetts BM. The nutrition and health transition in the North-West Province of South Africa: a review of the THUSA (Transition and Health during Urbanization of South Africa) study. Public Health Nutr. 2005;8(5): 480-490.
5. Johnson RJ, Kang D, Feig D, Kiclighn S, Kanellis J, Watanbe S, et al. Is there a pathogenic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41(6):1183-1190.
6. Longo-Mbenza B, Luila EL, Mbete P, Vita EK. Is hyperuricemia a risk factor of stroke and coronary heart disease among Africans? Int J Cardiol. 1999;71(1):17-22.
7. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan community cardiovascular cohort study. Atherosclerosis. 2005;183(1):147-155.
8. Hozawa A, Folsom AR, Ibrahim H, Javier Nieto F, Rosamond WD, Shahar E. Serum uric acid and risk of ischemic stroke: the ARIC study. Atherosclerosis. 2006;187(2):401-407.
9. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Available at: http:// www.nutritionandmetabolism.com.content/1/ 1/10. Accessed 7/19/2005.
10. Schutte AE, Kruger HS, Wissing MP, Underhay C, Vorster HH. The emergence of the metabolic syndrome in urban obese African women: The POWIRS study. S Afr J Sci. 2005;101(1/2):61-67.
11. World Health Organization. Obesity, preventing and managing the global epidemic. Report of a WHO consultation on obesity, June 3-5, 1997. Geneva.
12. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Available at: http://www.wma.net/e/policy/b3.htm. Accessed 4/12/2006.
13. Wesseling KH, Jansen JR, Settles JJ, Schreuder JJ. Computation of aortic flow from pressure in humans using a nonlinear, three-element model. J Appl Physiol. 1993;74(5):2566-2573.
14. Silke B, McAuley D. Accuracy and precision of blood pressure determination with the Finapres: an overview using resampling statistics. J Hum Hypertens. 1998;12(6):4093-4096.
15. Schutte AE, Huisman HW, Van Rooyen JM, Malan NT, Schutte R. Validation of the Finometer device for measurement of blood pressute in black women. J Hum Hypertens. 2004;18(2):79-84.
16. Imholz BP, Wieling W, Van Montfrants GA, Wesseling KH. Fifteen years of experience with finger arterial pressure monitoring: assessment of the technology. Cardiovasc Res. 1998;38(3): 605-616.
17. Langewouters GJ, Settles JJ, Roelandt R, Wesseling KH. Why use Finapres or Portapres rather than intra-arterial or intermitted non-invasive techniques of blood pressure measurement. J Med Eng Technol. 1998;22(1):37-43.
18. Norton K, Olds T. Anthropometrica: a Textbook of Body Measurements for Sports and Health Courses. Sydney: UNSW Press; 1996.
19. De Ridder JH. Die grondaspekte van kinantropometrie: 'n Handleiding vir studente. 3de Uitgawe.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor DF, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
21. Watanabe S, Kang DH, Feng L, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension. 2002; 40(3):355-360.
22. Hochberg MC, Thomas J, Thomas DJ, Mead L, Levine DM, Klag MJ. Racial differences in the incidence of gout. Arthritis Rheum. 1995;38(5):628-632.
23. Alderman MH. Uric acid and cardiovascular risk. Curr Opin Pharmacol. 2002;2(2): 126-130.
24. Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, Higashino K. Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism. 1997;46(10):1162-1165.
25. Miyatake N, Kogashiwa M, Wang DH, Kira S, Yamasato T, Fujii M. The relationship between visceral adipose tissue accumulation and biochemical tests in university students. Acta Med Okayama. 2005;59(4):129-134.
26. Yusuf S, Hawken S, Ôunpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-case control study. Lancet. 2005;366(9497): 1640-1649.
27. Dagenais GR, Yi Q, Mann JF, Bosch J, Pogue J, Yusuf S. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J. 2005;149(1):54-60.
28. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2005;52(1):283-289.
29. Fam AG. Gout: excess calories, purines, and alcohol intake and beyond. Response to a urate-lowering diet. J Rheumatol. 2005; 32(5):903-905.
30. Spitsin SV, Scott GS, Mikheeva R, et al. Comparison of uric acid and ascorbic acid in protection against EAE. Free Radic Biol Med. 2000;33(10):1363-1371.
31. Simon JA, Lin F, Vittinghoff E, Bittner V, for the Heart and Estrogen-Progestin Replacement Study (HERS) Research Group. The relation of postmenopausal hormone therapy to serum uric acid and the risk of cardiovascular heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS). Ann Epidemiol. 2006;16(x):138-145.
32. Wingrove CS, Walton C, Stevenson JC. The effect of menopause on serum uric acid levels in non-obese healthy women. Metabolism. 1998;47(4):435-438.